Clinical relevance: Using the Cancer Immunology Data Engine (CIDE; 90 datasets, 8,575 tumors), high CTSW expression—largely in T and NK cells—correlates with improved immunotherapy response and better overall survival across multiple cancers including melanoma and lung cancer.
